However, basal levels of inflammation are low in this population, and it is unknown how raising β-OHB with exogenous ketone ingestion affects NLRP3 activation in individuals who are at risk for developing metabolic diseases (e.g., obesity). Here, NLRP3 is linked to metabolic disease.